106 related articles for article (PubMed ID: 12224380)
1. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Dal SM; Bovio C; Culici M; Braga PC
Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
[TBL] [Abstract][Full Text] [Related]
2. Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.
Braga PC; Zuccotti T; Dal Sasso M
Chemotherapy; 2001; 47(3):208-14. PubMed ID: 11306790
[TBL] [Abstract][Full Text] [Related]
3. Effects of erdosteine and its metabolites on bacterial adhesiveness.
Braga PC; Dal Sasso M; Sala MT; Gianelle V
Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
[TBL] [Abstract][Full Text] [Related]
4. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
Wojnicz D; Jankowski S
Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bacterial adhesion by sub-inhibitory concentrations: brodimoprim vs trimethoprim.
Braga PC; Piatti G; Limoli A; Santoro M; Gazzola T
J Chemother; 1993 Dec; 5(6):447-52. PubMed ID: 8195836
[TBL] [Abstract][Full Text] [Related]
6. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
9. Effects of sub-minimum inhibitory concentrations of gatifloxacin on the inhibition of Staphylococcus aureus and Escherichia coli adherence.
Braga PC; Dal Sasso M
Arzneimittelforschung; 2002; 52(2):109-12. PubMed ID: 11878198
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
[TBL] [Abstract][Full Text] [Related]
11. Effects of subinhibitory concentrations of ciprofloxacin on enterotoxigenic Escherichia coli virulence factors.
Oviedo P; Quiroga M; Pegels E; Husulak E; Vergara M
J Chemother; 2000 Dec; 12(6):487-90. PubMed ID: 11154030
[TBL] [Abstract][Full Text] [Related]
12. [Modulation of P-fimbriation by ciprofloxacin in uropathogenic Escherichia coli].
Abalia I; Rodríguez E; Umaran A; Lacalle J; Sarasua A; Huarte M; Ramón Bilbao J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):255-9. PubMed ID: 9376383
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of ciprofloxacin-beta-cyclodextrin complex and its efficacy in dental implants.
Aithal KS; Udupa N; Varma BR; Kurian R
Indian J Dent Res; 1995; 6(4):123-8. PubMed ID: 9495116
[TBL] [Abstract][Full Text] [Related]
14. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin.
Mortensen NP; Fowlkes JD; Maggart M; Doktycz MJ; Nataro JP; Drusano G; Allison DP
Int J Antimicrob Agents; 2011 Jul; 38(1):27-34. PubMed ID: 21570813
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
[TBL] [Abstract][Full Text] [Related]
17. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex.
Adepoju-Bello AA; Coker HA; Eboka CJ; Abioye AO; Ayoola GA
Nig Q J Hosp Med; 2008; 18(3):133-6. PubMed ID: 19062475
[TBL] [Abstract][Full Text] [Related]
18. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
Sharma V; Sharma S; Garg P; Rao GN
Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
[TBL] [Abstract][Full Text] [Related]
19. [Effect of subinhibitory doses of some antibiotics on bacteria in vitro].
Denys A; Kalisz J; Szczerba W; Kowalska M
Med Dosw Mikrobiol; 1994; 46(3):181-94. PubMed ID: 7996936
[TBL] [Abstract][Full Text] [Related]
20. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Dal Sasso M; Culici M; Guffanti EE; Bianchi T; Fonti E; Braga PC
Pharmacology; 2005 Jun; 74(3):127-34. PubMed ID: 15753624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
